文献速递产科

枕神经阻滞与对乙酰氨基酚加咖啡因治疗妊娠期头痛的比较:一项随机对照试验

Occipital Nerve Block Compared With Acetaminophen and Caffeine for Headache Treatment in Pregnancy: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2023-09-28

该单中心、非盲、平行随机对照试验纳入62例妊娠期急性头痛且视觉评分量表评分高于3分的患者,比较枕神经阻滞与标准治疗(口服650 mg对乙酰氨基酚和200 mg咖啡因)。主要结局(2小时内视觉评分量表评分降至3分或以下)两组无显著差异(64.5% vs 51.6%,P=.30),但枕神经阻滞组1小时评分更低,结论认为枕神经阻滞是有效且起效快的治疗选择。

要点

  • 主要结局2小时内评分降至3分或以下两组无显著差异(64.5% vs 51.6%,P=.30)。
  • 枕神经阻滞组1小时中位视觉评分量表评分更低(2 vs 6,P=.014)。
  • 枕神经阻滞组分娩更早(36.6周 vs 37.8周),但早产率两组无差异。

核心结论

  • 枕神经阻滞是妊娠期急性头痛有效且起效快的治疗选择。

研究设计与样本

  • 单中心、非盲、平行随机对照试验,纳入妊娠期头痛且视觉评分量表评分高于3分的患者,排除继发性头痛、子痫前期或对研究药物过敏或禁忌者。
  • 2020年2月至2022年5月共随机62例,枕神经阻滞组31例,标准治疗组31例,按意向性分析评估结局。
  • 样本量62例预计提供80%把握度检测两组85%至50%的差异。

主要发现

  • 主要结局(2小时内视觉评分量表评分降至3分或以下)两组无显著差异(64.5% vs 51.6%,P=.30)。
  • 枕神经阻滞组1小时中位(四分位距)视觉评分量表评分更低(2 [0-5] vs 6 [2-7],P=.014),且1小时评分降至3分或以下者更多。
  • 2小时接受交叉治疗的患者中,标准治疗组交叉至枕神经阻滞后1小时评分显著低于枕神经阻滞组交叉至标准治疗(P=.028)。
  • 二线治疗、难治性头痛、满意度或并发症方面无显著差异;枕神经阻滞组分娩更早(36.6周 vs 37.8周),但早产率两组无差异。

关键数值与推荐

  • 标准治疗定义为口服650 mg对乙酰氨基酚和200 mg咖啡因。
  • 主要结局为初始治疗后2小时内视觉评分量表评分降至3分或以下。
  • 交叉治疗在2小时给予,二线治疗在4小时给予,适用于视觉评分量表评分恶化或高于3分者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the efficacy of occipital nerve block compared with standard care , defined as acetaminophen with caffeine, for treatment of acute headache in pregnancy. METHODS: We conducted a single-center, unblinded, parallel, randomized controlled trial of pregnant patients with headache and pain score higher than 3 on the visual rating scale. Patients with secondary headache, preeclampsia, or allergy or contraindication to study medications were excluded. Participants were randomized to occipital nerve block or standard care (oral 650 mg acetaminophen and 200 mg caffeine). Crossover treatment was given at 2 hours and second-line treatment at 4 hours to those with worsening visual rating scale score or visual rating scale score higher than 3. The primary outcome was headache improvement to a visual rating scale score of 3 or lower within 2 hours of initial therapy. Secondary outcomes included serial visual rating scale scores, receipt of crossover or second-line therapy, patient satisfaction, and perinatal outcomes. Outcomes were assessed in an intention-to-treat analysis. We estimated that a sample of 62 would provide 80% power to detect a difference from 85% to 50% between groups. RESULTS: From February 2020 to May 2022, 62 participants were randomized to occipital nerve block (n=31) or standard care (n=31). Groups were similar except payer status. The primary outcome, headache improvement to visual rating scale score of 3 or lower, was not significantly different between groups (64.5% vs 51.6%, P =.30). The occipital nerve block group experienced lower median [interquartile range] visual rating scale scores at 1 hour (2 [0-5] vs 6 [2-7], P =.014), and more patients in the occipital nerve block group had visual rating scale scores of 3 or lower at 1 hour. Among patients receiving crossover treatment at 2 hours, the standard care group had a significantly lower visual rating scale score 1 hour after crossover to occipital nerve block than the occipital nerve block group receiving crossover to standard care ( P =.028). There were no significant differences in second-line treatment, refractory headache, satisfaction, or complications. Patients receiving occipital nerve block delivered earlier (36.6 weeks vs 37.8 weeks), but preterm birth did not differ between groups. CONCLUSION: Occipital nerve block is an effective and quick-acting treatment option for acute headache in pregnancy. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov , NCT03951649.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bushman ET, Blanchard CT, Cozzi GD, et al. Occipital Nerve Block Compared With Acetaminophen and Caffeine for Headache Treatment in Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2023. PMID: 37769308. doi:10.1097/AOG.0000000000005386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。